A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS

Authors


  • *

    This paper is published with the approval of the Saskatchewan Committee for Schizophrenia Research using funds provided by the National Department of Health and Welfare, Ottawa, Ontario; Psychiatric Service; Branch, Department of Public Health, the Provincial Government of Saskatchewan, Regina, Saskatchewan; and The Rockefeller Foundation, New York, N. Y.

Ancillary